Patient and Provider Education: Addressing Primary Immunodeficiencies within Minority/Underserved; Awareness of Drug Resistant Infections - May deadlines

Sponsor Deadline: 

May 25, 2021


Pfizer Global Medical

UI Contact: 

 Addressing Primary Immunodeficiencies within Minority/Underserved Populations
 Through this RFP, it is our intent to support patient and provider educational programs on the awareness, diagnosis, and treatment of primary immunodeficiencies within minority/underserved populations.
deadline May 25, 2021

Patient and Caregiver Awareness of Drug Resistant Infections
Projects that will be considered for Pfizer support will focus on patient and caregiver awareness on the importance of appropriate use of intravenous or home infusion anti-infectives (antibiotics or antifungals) as a part of chronic disease management, including oncology, diabetes, hematology, immunology, renal disorders, rheumatology, pulmonology, and patients with long-term hospital stays. Projects that will be considered should include a focus on patient and caregiver awareness and education that will support the initial diagnosis, treatment of bacterial and/or fungal infections and also increase patient awareness of the need for appropriate use of anti-infectives and prevention measures. Programs that strive to reduce health disparities by following principles of health literacy will be prioritized along with programs that aid in a close coordination of care between HCPs and patients.
Deadline May 19, 2021

The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.